These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9000573

  • 21. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
    Sure U, Rüedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P, Hegi ME.
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
    [Abstract] [Full Text] [Related]

  • 22. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM, Jassem E, Rosell R, Martínez-Roca M, Jassem J, Martínez-López E, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M.
    Oncogene; 1997 Dec 11; 15(24):2951-8. PubMed ID: 9416838
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S, Tavolaro S, Marinelli M, Messina M, Del Giudice I, Mauro FR, Santangelo S, Piciocchi A, Peragine N, Truong S, Patten N, Ghia EM, Torrente I, De Propris MS, Nanni M, Lawrence J, Guarini A, Foà R.
    Genes Chromosomes Cancer; 2011 Apr 11; 50(4):263-74. PubMed ID: 21319261
    [Abstract] [Full Text] [Related]

  • 24. IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
    Thon N, Eigenbrod S, Kreth S, Lutz J, Tonn JC, Kretzschmar H, Peraud A, Kreth FW.
    Cancer; 2012 Jan 15; 118(2):452-60. PubMed ID: 21717448
    [Abstract] [Full Text] [Related]

  • 25. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL.
    Cancer; 2003 Sep 15; 98(6):1243-52. PubMed ID: 12973849
    [Abstract] [Full Text] [Related]

  • 26. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S, Chapman W, McLaughlin J, Andrulis IL.
    Cancer J; 2000 Sep 15; 6(5):302-8. PubMed ID: 11079169
    [Abstract] [Full Text] [Related]

  • 27. Correlation of p53 immunoreactivity and sequencing in patients with glioma.
    Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM.
    Mol Carcinog; 1996 Jan 15; 15(1):1-4. PubMed ID: 8561860
    [Abstract] [Full Text] [Related]

  • 28. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.
    Bredel M, Pollack IF, Campbell JW, Hamilton RL.
    Clin Cancer Res; 1997 Nov 15; 3(11):2157-64. PubMed ID: 9815610
    [Abstract] [Full Text] [Related]

  • 29. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.
    Clin Cancer Res; 1995 Jul 15; 1(7):775-81. PubMed ID: 9816045
    [Abstract] [Full Text] [Related]

  • 30. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, ter Elst A, Mulder NH, Buys CH, Hofstra RM, Plukker JT.
    J Clin Oncol; 2005 Aug 20; 23(24):5635-43. PubMed ID: 16110022
    [Abstract] [Full Text] [Related]

  • 31. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 20; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 32. p53 status has no prognostic significance in glioblastomas treated with radiotherapy.
    Baxendine-Jones J, Campbell I, Ellison D.
    Clin Neuropathol; 1997 Apr 20; 16(6):332-6. PubMed ID: 9401801
    [Abstract] [Full Text] [Related]

  • 33. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era.
    Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, Rorke L, Sutton LN, Phillips PC, Shu HK.
    Cancer; 2004 Aug 15; 101(4):817-24. PubMed ID: 15305415
    [Abstract] [Full Text] [Related]

  • 34. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.
    Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573
    [Abstract] [Full Text] [Related]

  • 35. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J.
    Acta Oncol; 2008 Apr 15; 47(4):600-7. PubMed ID: 18465328
    [Abstract] [Full Text] [Related]

  • 36. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.
    Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL.
    J Clin Oncol; 2005 Mar 01; 23(7):1483-90. PubMed ID: 15735124
    [Abstract] [Full Text] [Related]

  • 37. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):14-9. PubMed ID: 18068527
    [Abstract] [Full Text] [Related]

  • 38. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 39. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Tsuchiya S, Nakagawa K, Hayashi J, Tsuchiya E.
    Cancer Res; 1999 Nov 01; 59(21):5572-7. PubMed ID: 10554037
    [Abstract] [Full Text] [Related]

  • 40. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL, Children's Oncology Group.
    J Neurosurg; 2006 Nov 01; 105(5 Suppl):418-24. PubMed ID: 17328268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.